tiprankstipranks
Pro Medicus Limited (PMCUF)
OTHER OTC:PMCUF
US Market
PMCUF
Pro Medicus Limited
RESEARCH TOOLSreports

Pro Medicus Limited (PMCUF) Stock Forecast & Price Target

40 Followers
See the Price Targets and Ratings of:

PMCUF Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
7 Buy
3 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Pro
Medicus Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PMCUF Stock 12 Month Forecast

Average Price Target

$158.04
▲(21.24% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Pro Medicus Limited in the last 3 months. The average price target is $158.04 with a high forecast of $172.30 and a low forecast of $139.99. The average price target represents a 21.24% change from the last price of $130.35.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"85":"$85","202":"$202","114.25":"$114.3","143.5":"$143.5","172.75":"$172.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":172.296,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$172.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":158.0377881,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$158.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":139.9905,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$139.99</span>\n  </div></div>","useHTML":true}}],"tickPositions":[85,114.25,143.5,172.75,202],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,113.075,117.63046153846155,122.18592307692307,126.74138461538462,131.29684615384616,135.8523076923077,140.40776923076922,144.96323076923076,149.5186923076923,154.07415384615385,158.62961538461536,163.1850769230769,167.74053846153845,{"y":172.296,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,113.075,116.5336760076923,119.99235201538461,123.45102802307693,126.90970403076923,130.36838003846154,133.82705604615384,137.28573205384615,140.74440806153845,144.20308406923078,147.6617600769231,151.1204360846154,154.5791120923077,{"y":158.0377881,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,113.075,115.14542307692308,117.21584615384616,119.28626923076924,121.35669230769231,123.42711538461539,125.49753846153847,127.56796153846153,129.6383846153846,131.7088076923077,133.77923076923076,135.84965384615384,137.92007692307692,{"y":139.9905,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":201.601,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.386,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.981,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.417,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":179.492,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.192,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.032,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.758,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.03,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.87,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.075,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$172.30Average Price Target$158.04Lowest Price Target$139.99
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on PMCUF
David Stanton
Jefferies
Jefferies
$135.14→$141.39
Hold
8.47%
Upside
Reiterated
08/20/26
Pro Medicus Limited (PMCUF) Receives a Hold from Jefferies
Morgan Stanley Analyst forecast on PMCUF
Chris Boulus
Morgan Stanley
Morgan Stanley
$157.94
Buy
21.16%
Upside
Reiterated
08/20/26
Pro Medicus Limited (PMCUF) Receives a Buy from Morgan Stanley
J.P. Morgan Analyst forecast on PMCUF
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$151.48
Hold
16.21%
Upside
Reiterated
08/19/26
J.P. Morgan Sticks to Its Hold Rating for Pro Medicus Limited (PMCUF)
Ord Minnett Analyst forecast on PMCUF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$165.12
Buy
26.67%
Upside
Reiterated
08/19/26
Ord Minnett Keeps Their Buy Rating on Pro Medicus Limited (PMCUF)
Bell Potter Analyst forecast on PMCUF
John Hester
Bell Potter
Bell Potter
$162.25
Buy
24.47%
Upside
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (Other OTC: COGZF), Pro Medicus Limited (Other OTC: PMCUF) and Cochlear (Other OTC: CHEOF)
MA Financial Group Analyst forecast on PMCUF
Sarah Mann
MA Financial Group
MA Financial Group
$164
Buy
25.81%
Upside
Reiterated
08/19/26
MA Financial Group Keeps Their Buy Rating on Pro Medicus Limited (PMCUF)
Morgans Analyst forecast on PMCUF
Iain Wilkie
Morgans
Morgans
$165.12
Buy
26.67%
Upside
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (Other OTC: PMCUF) and CSL (Other OTC: CMXHF)
RBC Capital Analyst forecast on PMCUF
Jackson Lee
RBC Capital
RBC Capital
$136.4→$139.99
Hold
7.40%
Upside
Reiterated
08/18/26
RBC Capital Keeps Their Hold Rating on Pro Medicus Limited (PMCUF)
Macquarie Analyst forecast on PMCUF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$158.66→$160.81
Buy
23.37%
Upside
Reiterated
07/31/26
Macquarie Sticks to Their Buy Rating for Pro Medicus Limited (PMCUF)
Citi Analyst forecast on PMCUF
Laura Sutcliffe
Citi
Citi
$172.3
Buy
32.18%
Upside
Reiterated
07/15/26
Pro Medicus Limited (PMCUF) Receives a Buy from Citi
Canaccord Genuity Analyst forecast on PMCUF
Madeleine Williams
Canaccord Genuity
Canaccord Genuity
$129.81→$121.05
Buy
-7.13%
Downside
Reiterated
05/12/26
Canaccord Genuity Sticks to Its Buy Rating for Pro Medicus Limited (PMCUF)
Goldman Sachs Analyst forecast on PMCUF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$244.8→$193.83
Buy
48.70%
Upside
Reiterated
02/05/26
Goldman Sachs Reaffirms Their Buy Rating on Pro Medicus Limited (PMCUF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on PMCUF
David Stanton
Jefferies
Jefferies
$135.14→$141.39
Hold
8.47%
Upside
Reiterated
08/20/26
Pro Medicus Limited (PMCUF) Receives a Hold from Jefferies
Morgan Stanley Analyst forecast on PMCUF
Chris Boulus
Morgan Stanley
Morgan Stanley
$157.94
Buy
21.16%
Upside
Reiterated
08/20/26
Pro Medicus Limited (PMCUF) Receives a Buy from Morgan Stanley
J.P. Morgan Analyst forecast on PMCUF
Unknown Analyst
J.P. Morgan
Not Ranked
J.P. Morgan
$151.48
Hold
16.21%
Upside
Reiterated
08/19/26
J.P. Morgan Sticks to Its Hold Rating for Pro Medicus Limited (PMCUF)
Ord Minnett Analyst forecast on PMCUF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$165.12
Buy
26.67%
Upside
Reiterated
08/19/26
Ord Minnett Keeps Their Buy Rating on Pro Medicus Limited (PMCUF)
Bell Potter Analyst forecast on PMCUF
John Hester
Bell Potter
Bell Potter
$162.25
Buy
24.47%
Upside
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (Other OTC: COGZF), Pro Medicus Limited (Other OTC: PMCUF) and Cochlear (Other OTC: CHEOF)
MA Financial Group Analyst forecast on PMCUF
Sarah Mann
MA Financial Group
MA Financial Group
$164
Buy
25.81%
Upside
Reiterated
08/19/26
MA Financial Group Keeps Their Buy Rating on Pro Medicus Limited (PMCUF)
Morgans Analyst forecast on PMCUF
Iain Wilkie
Morgans
Morgans
$165.12
Buy
26.67%
Upside
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (Other OTC: PMCUF) and CSL (Other OTC: CMXHF)
RBC Capital Analyst forecast on PMCUF
Jackson Lee
RBC Capital
RBC Capital
$136.4→$139.99
Hold
7.40%
Upside
Reiterated
08/18/26
RBC Capital Keeps Their Hold Rating on Pro Medicus Limited (PMCUF)
Macquarie Analyst forecast on PMCUF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$158.66→$160.81
Buy
23.37%
Upside
Reiterated
07/31/26
Macquarie Sticks to Their Buy Rating for Pro Medicus Limited (PMCUF)
Citi Analyst forecast on PMCUF
Laura Sutcliffe
Citi
Citi
$172.3
Buy
32.18%
Upside
Reiterated
07/15/26
Pro Medicus Limited (PMCUF) Receives a Buy from Citi
Canaccord Genuity Analyst forecast on PMCUF
Madeleine Williams
Canaccord Genuity
Canaccord Genuity
$129.81→$121.05
Buy
-7.13%
Downside
Reiterated
05/12/26
Canaccord Genuity Sticks to Its Buy Rating for Pro Medicus Limited (PMCUF)
Goldman Sachs Analyst forecast on PMCUF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$244.8→$193.83
Buy
48.70%
Upside
Reiterated
02/05/26
Goldman Sachs Reaffirms Their Buy Rating on Pro Medicus Limited (PMCUF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
AXGNAxoGen
ATECAlphatec Holdings
CABACabaletta Bio
ONCBeOne Medicines
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pro Medicus Limited

3 Months
Iain WilkieMorgans
Success Rate
11/18 ratings generated profit
61%
Average Return
+17.68%
Copying Iain Wilkie's trades and holding each position for 3 Months would result in 61.11% of your transactions generating a profit, with an average return of +17.68% per trade.
1 Year
Iain WilkieMorgans
Success Rate
15/18 ratings generated profit
83%
Average Return
+46.83%
Copying Iain Wilkie's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +46.83% per trade.
2 Years
Iain WilkieMorgans
Success Rate
16/18 ratings generated profit
89%
Average Return
+58.89%
Copying Iain Wilkie's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +58.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PMCUF Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
11
5
7
4
2
Buy
4
5
4
6
9
Hold
4
3
4
7
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
13
15
17
21
In the current month, PMCUF has received 11 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. PMCUF average Analyst price target in the past 3 months is 158.04.
Each month's total comprises the sum of three months' worth of ratings.

PMCUF Financial Forecast

PMCUF Earnings Forecast

Next quarter’s earnings estimate for PMCUF is $0.60 with a range of $0.58 to $0.62. The previous quarter’s EPS was $0.53. PMCUF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PMCUF has Performed in-line its overall industry.
Next quarter’s earnings estimate for PMCUF is $0.60 with a range of $0.58 to $0.62. The previous quarter’s EPS was $0.53. PMCUF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PMCUF has Performed in-line its overall industry.

PMCUF Sales Forecast

Next quarter’s sales forecast for PMCUF is $115.66M with a range of $112.33M to $117.54M. The previous quarter’s sales results were $97.83M. PMCUF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PMCUF has Performed in-line its overall industry.
Next quarter’s sales forecast for PMCUF is $115.66M with a range of $112.33M to $117.54M. The previous quarter’s sales results were $97.83M. PMCUF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PMCUF has Performed in-line its overall industry.

PMCUF Stock Forecast FAQ

What is PMCUF’s average 12-month price target, according to analysts?
Based on analyst ratings, Pro Medicus Limited’s 12-month average price target is 158.04.
    What is PMCUF’s upside potential, based on the analysts’ average price target?
    Pro Medicus Limited has 21.24% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PMCUF a Buy, Sell or Hold?
          Pro Medicus Limited has a consensus rating of Moderate Buy which is based on 7 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Pro Medicus Limited’s price target?
            The average price target for Pro Medicus Limited is 158.04. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $172.30 ,the lowest forecast is $139.99. The average price target represents 21.24% Increase from the current price of $130.35.
              What do analysts say about Pro Medicus Limited?
              Pro Medicus Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of PMCUF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.